Portal de Periódicos da CAPES

Dietary fat composition and the metabolic syndrome

2004; Wiley; Volume: 106; Issue: 1 Linguagem: Inglês

10.1002/ejlt.200300902

1438-9312

Salvatore Panico, Marcello Arca,

Fatty Acid Research and Health

European Journal of Lipid Science and TechnologyVolume 106, Issue 1 p. 61-67 Review Article Dietary fat composition and the metabolic syndrome Salvatore Panico, Corresponding Author Salvatore Panico [email protected] Dipartimento di Medicina Clinica e Sperimentale, Università Federico II, Via Pansini 5, 80131 Napoli, Italy. Phone: +39-081-7463687, Fax +39-081-5466152Dipartimento di Medicina Clinica e Sperimentale, Università Federico II, Via Pansini 5, 80131 Napoli, Italy. Phone: +39-081-7463687, Fax +39-081-5466152Search for more papers by this authorArcangelo Iannuzzi, Arcangelo Iannuzzi Division of Internal Medicine, Ospedale S. Maria dell'Olmo, Cava dei Tirreni, Salerno, ItalySearch for more papers by this author Salvatore Panico, Corresponding Author Salvatore Panico [email protected] Dipartimento di Medicina Clinica e Sperimentale, Università Federico II, Via Pansini 5, 80131 Napoli, Italy. Phone: +39-081-7463687, Fax +39-081-5466152Dipartimento di Medicina Clinica e Sperimentale, Università Federico II, Via Pansini 5, 80131 Napoli, Italy. Phone: +39-081-7463687, Fax +39-081-5466152Search for more papers by this authorArcangelo Iannuzzi, Arcangelo Iannuzzi Division of Internal Medicine, Ospedale S. Maria dell'Olmo, Cava dei Tirreni, Salerno, ItalySearch for more papers by this author First published: 08 January 2004 https://doi.org/10.1002/ejlt.200300902Citations: 12AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL REFERENCES 1 G. M. Reaven: Pathophysiology of insulin resistance in human disease. Physiol. Rev. 75 (1995) 473– 486. 2 S. M. Grundy: Hypertriclyceridemia, insulin resistance, and the metabolic syndrome. Am. J. Cardiol. 83 (1999) 25F– 29F. 3 J. B. Meigs: Invited commentary: insulin resistance syndrome? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals pattern in the fabric of correlated risk factors. Am. J. Epidemiol. 152 (2000) 908– 911. 4 G. Riccardi, A. A. Rivellese: Dietary treatment of the metabolic syndrome - the optimal diet. Br. J. Nutr. 83 (Suppl. 1) (2000) S 143–S 148. 5 S. M. Grundy, N. Abate, M. Chandalia: Diet composition and the metabolic syndrome: what is the optimal fat intake? Am. J. Med. 30 (2002) 113; Suppl 9B 25S– 29S. 6 Am. Med. Assoc.: Executive summary of the third report of the national cholesterol education program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). J. Am. Med. Assoc. 285 (2001) 2486– 2497. 7 K. Alberti, P. Zimmet: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus - provisional report of a WHO consultation. Diabetes Med. 15 (1998) 539– 553. 8 B. Vessby: Dietary fat, fatty acid composition in plasma and the metabolic syndrome. Curr. Opin. Lipidol. 14 (2003) 15– 19. 9 Y.-W. Park, S. Zhu, L. Palaniappan, S. Heshka, M. R. Carnethon, S. B. Heymsfield: The metabolic syndrome. Prevalence and associated risk factor findings in the US population from the third NANHES, 1988-1994. Arch. Intern. Med. 163 (2003) 427– 436. 10 P. W. F. Wilson, R. B. D'Agostino, D. Levy, A. M. Belanger, H. Silbershatz, W. B. Kannel: Prediction of coronary heart disease using risk factor categories. Circulation 97 (1998) 1837– 1847. 11 National Institute of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults - the evidence report. Obesity Res. 6 (suppl. 2) (1998) 51S– 209S. 12 R. H. Eckel, R. M. Krauss, for the AHA Nutrition committee: American Heart Association call to action: obesity as a major risk factor for coronary heart disease. Circulation 97 (1998) 2099– 2100. 13 G. Assmann, P. Cullen, H. Schulte: The Munster Heart Study (PROCAM): results of follow-up at 8 years. Eur. Heart J. 19(suppl.A) (1998) A 2–A 11. 14 L. C. Groop: Insulin resistance: the fundamental trigger of type 2 diabetes. Diabetes Obes. Metab. 1(suppl.1) (1999) S 1–S 7. 15 M. K. Cavaghan, D. A. Ehrmann, K. S. Polonsky: Interaction between insulin resistance and insulin secretion in the development of glucose intolerance. J. Clin. Invest. 106 (2000) 329– 333. 16 E. S. Ford, W. H. Giles, W. H. Dietz: Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. J. Am. Med. Assoc. 287 (2002) 356– 359. 17 Diabetes Prevention Program Research Group: Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin. N. Engl. J. Med. 346 (2002) 393– 403. 18 J. Tuomilehto, J. Lindstrom, J. G. Eriksson, T. T. Valle, H. Hamalainen, P. Ilanne-Parikka, S. Keinanen-Kiukaanniemi, M. Laakso, A. Louheranta, M. Rastas, V. Salminen, S. Aunola, Z. Cepaitis, V. Moltchanov, M. Hakumaki, M. Mannelin, V. Martikkala, J. Sundvall, M. Uusitupa, for the Finnish Diabetes Prevention Study Group: Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance. N. Engl. J. Med. 344 (2001) 1343– 1350. 19 D. R. Dengel, A. T. Galecki, J. M. Hagberg, R. E. Pratley: The independent and combined effects of weight loss and aerobic exercise on blood pressure and oral glucose tolerance in older men. Am. J. Hypertens. 11 (1998) 1405– 1411. 20 F. Ahmad, R.V. Considine, T. L. Bauer, J. P. Ohannesian, C. C. Marco, B. J. Goldstein: Improved sensitivity to insulin in obese subjects following weight loss is accompanied by reduced protein-tyrosine phosphatases in adipose tissue. Metabolism 46 (1997) 1140– 1145. 21 H.-Y. Su, W. H. Sheu, H.-M. Chin, C. Jeng, Y.-D. Yhen, G. M. Reaven: Effect of weight loss on blood pressure and insulin resistance in normotensive and hypertensive obese individuals. Am. J. Hypertens. 8 (1995) 1067– 1071. 22 J. T. Devlin: Effects of exercise on insulin sensitivity in humans. Diabetes Care 15 (1992) 1690– 1693. 23 G. Perseghin, T. B. Price, K. F. Petersen, M. Roden, G. W. Cline, K. Gerow, D. L. Rothman, G. I. Shulman: Increased glucose transport-phosphorylation and muscle glycogen synthesis after exercise training in insulin resistant subjects. N. Engl. J. Med. 335 (1996) 1357– 1362. 24 National Institutes of Health. National Heart, Lung, and Blood Institute: Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: The Evidence Report: National Institutes of Health, Washington, DC (USA) 1998. Available at: http://www.nhlbi.nih.gov/guidelines/obesity/e_txtbk/ index.htm. 25 D. J. Goldstein: Beneficial health effects of a modest weight loss. Int. J. Obes. 16 (1992) 397– 415. 26 WHO: Obesity, preventing and managing the global epidemic: report of the WHO consultation of obesity. World Health Organization, Geneva (Switzerland) 1997. 27 M. Haftenberger, P. H. Lahmann, S. Panico, C. A. Gonzalez, J. C. Seidell, H. Boeing, M. C. Giurdanella, V. Krogh, H. B. Bueno-de-Mesquita, P. H. Peeters, G. Skeie, A. Hjartaker, M. Rodriguez, J. R. Quiros, G. Berglund, U. Janlert, K. T. Khaw, E. A. Spencer, K. Overvad, A. Tjonneland, F. Clavel-Chapelon, B. Tehard, A. B. Miller, K. Klipstein-Grobusch, V. Benetou, G. Kiriazi, E. Riboli, N. Slimani: Overweight, obesity and fat distribution in 50- to 64-year-old participants in the European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutr. 5 (2002) 1147– 62. 28 J. P. Foreyt, W. S. C. Poston, II: Consensus view on the role of dietary fat and obesity. Am. J. Med. 113 (Suppl 9B) (2002) 60S– 62S. 29 W. C. Willett, R. L. Leibel: Dietary fat is not a major determinant of body fat. Am. J. Med. 113 (Suppl 9B) (2002) 60S– 62S. 30 W. C. Willett: Dietary fat and obesity: an unconvincing relation. Am. J. Clin. Nutr. 68 (1998) 1149– 1150. 31 S. Beer-Borst, A. Morabia, S. Hercberg, O. Vitek, M. S. Bernstein, P. Galan, R. Galasso, S. Giampaoli, S. Houterman, E. McCrum, S. Panico, F. Pannozzo, P. Preziosi, L. Ribas, L. Serra-Majem, W. M. Verschuren, J. Yarnell, M. E. Northridge: Obesity and other health determinants across Europe: the EURALIM project. J. Epidemiol. Community Health 54 (2000) 424– 30. 32 G. A. Bray, B. M. Popkin: Dietary fat intake does affect obesity. Am. J. Clin. Nutr. 68 (1998) 1157– 1173. 33 E. Jéquier, G. A. Bray: Low-fat diets are preferred. Am. J. Med. 113 (Suppl 9B) (2002) 41S– 46S. 34 W. E. Connor, S. L. Connor: The case for a low-fat, high carbohydrate diet. N. Engl. J. Med. 337 (1997) 562– 563. 35 F. F. Samaha, N. Iqbal, P. Seshadri, K. L. Chicano, D. A. Daily, J. McGrory, T. Williams, M. Williams, E. J. Gracely, L. Stern: A low-carbohydrate as compared with a low-fat diet in severe obesity. N. Engl. J. Med. 348 (2003) 2074– 2081. 36 G. D. Foster, H. R. Wyatt, J. O. Hill, B. G. McGuckin, C. Brill, B. S. Mohammed, P. O. Szapary, D. J. Rader, J. S. Edman, S. Klein: A randomized trial on a low-carbohydrate diet for obesity. N. Engl. J. Med. 348 (2003) 2082– 2090. 37 A. Keys, J. T. Anderson, F. Grande: Serum cholesterol response to changes in diet. III Difference among individuals. Metabolism 14 (1965) 766– 775. 38 L. Hooper, C. D. Summerbell, J. P. Higgins, R. L. Thompson, G. Clements, N. Capps, S. Davey, R. A. Riemersma, S. Ebrahim: Reduced or modified dietary fat for preventing cardiovascular disease. Cochrane Database Syst. Rev. 3 (2001) CD002137. 39 S. Yoshioka, K. Uemura, N. Tamaya, T. Tamagawa, H. Miura, A. Iguchi, J. Nakamura, N. Hotta: Dietary fat-induced increase in blood pressure and insulin resistance in rats. J. Hypert. 18 (2000) 1857– 1864. 40 L. N. Kaufman, M. M. Peterson, S. M. Smith: Hypertension and sympathetic hyperactivity induced in rats by high-fat or glucose diets. Am. J. Physiol. 260 (1991) E 95– 100. 41 K. Ajiro, M. Sawamura, K. Ikeda, Y. Nara, M. Nishimura, H. Ishida, Y. Seino, Y. Yamori: Beneficial effects of fish oil on glucose metabolism in spontaneously hypertensive rats. Clin. Exp. Pharmacol. Physiol. 27 (2000) 412– 415. 42 S. C. Langley-Evans, A. G. Clamp, R. F. Grimble, A. A. Jackson: Influence of dietary fats upon systolic blood pressure in the rat. Int. J. Food Sci. Nutr. 47 (1996) 417– 425. 43 N. Karanja, T. Phanouvong, D. A. McCarron: Blood pressure in spontaneously hypertensive rats fed butterfat, corn oil or fish oil. Hypertension 14 (1989) 674– 679. 44 M. M. Engler, M. B. Engler, T. L. Goodfriend, D. L. Ball, Z. Yu, P. Su, D. L. Kroetz: Docosahexaenoic acid is an antihypertensive nutrient that affects aldosterone production in SHR. Proc. Soc. Exp. Biol. Med. 221 (1999) 32– 38. 45 T. Vaskonen, J. Laakso, E. Mervaala, E. Sievi, H. Karppanen: Interrelationships between salt and fish oil in stroke-prone spontaneously hypertensive rats. Blood Press. 5 (1996) 178– 189. 46 S. Kimura, M. Minami, H. Saito, T. Kobayashi, H. Okuyama: Dietary docosahexaenoic acid (22: 6n-3) prevents the development of hypertension in SHRSP. Clin. Exp. Pharmacol. Physiol. Suppl. 22 (1995) S 308– 309. 47 M. Trevisan, V. Krogh, J. L. Freudenheim, A. Blake, P. Muti, S. Panico, E. Farinaro, M. Mancini, A. Menotti, G. Ricci: Diet and coronary heart disease risk factors in a population with varied intake. The Research Group ATS-RF2 of The Italian National Research Council. Prev. Med. 19 (1990) 231– 241. 48 S. Grimsgaard, K. H. Bonaa, B. K. Jacobsen, K. S. Bjerve: Plasma saturated and linoleic fatty acids are independently associated with blood pressure. Hypertension 34 (1999) 478– 483. 49 J. Stamler, K. Liu, K. R. Ruth, J. Pryer, P. Greenland: Eight-year blood pressure changes in middle-aged men: relationship to multiple nutrients. Hypertension 39 (2002) 1000– 1006. 50 J. M. Iacono, R. M. Dougherty, P. Puska, P. Pietinen: Dietary polyunsaturated fat and hypertension. Ann. Med. 21 (1989) 251– 254. 51 P. Puska, J. M. Iacono, A. Nissinen, H. J. Korhonen, E. Vartiainen, P. Pietinen, R. Dougherty, U. Leino, M. Mutanen, S. Moisio, J. Huttunen: Controlled, randomised trial of the effect of dietary fat on blood pressure. Lancet 1 (1983) 1– 5. 52 A. Aro, P. Pietinen, L. M. Valsta, I. Salminen, A. M. Turpeinen, M. Virtanen, R. M. Dougherty, J. M. Iacono: Lack of effect on blood pressure by low fat diets with different fatty acid compositions. J. Hum. Hypertens. 12 (1998) 383– 389. 53 M. Mutanen, P. Kleemola, L. M. Valsta, R. P. Mensink, L. Rasanen: Lack of effect on blood pressure by polyunsaturated and monounsaturated fat diets. Eur. J. Clin. Nutr. 46 (1992) 1– 6. 54 F. M. Sacks, I. L. Rouse, M. J. Stampfer, L. M. Bishop, C. F. Lenherr, R. J. Walther: Effect of dietary fats and carbohydrate on blood pressure of mildly hypertensive patients. Hypertension 10 (1987) 452– 460. 55 L. A. Ferrara, A. S. Raimondi, L. d'Episcopo, L. Guida, A. Dello Russo, T. Marotta: Olive oil and reduced need for antihypertensive medications. Arch. Intern. Med. 160 (2000) 837– 842. 56 J. M. Geleijnse, E. J. Giltay, D. E. Grobbee, A. R. Donders, F. J. Kok: Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials. J. Hypertens. 20 (2002) 1493– 1499. 57 M. C. Morris, F. Sacks, B. Rosner: Does fish oil lower blood pressure? A meta-analysis of controlled trials. Circulation 88 (1993) 523– 533. 58 V. Salomaa, I. Ahola, J. Tuomilehto, A. Aro, P. Pietinen, H. J. Korhonen, I. Penttila: Fatty acid composition of serum cholesterol esters in different degrees of glucose intolerance: a population-based study. Metabolism 39 (1990) 1285– 1291. 59 B. Vessby, S. Tengblad, H. Lithell: Insulin sensitivity is related to the fatty acid composition of serum lipids and skeletal muscle phospholipids in 70-year-old men. Diabetologia 37 (1994) 1044– 1050. 60 B. Vessby, M. Unsitupa, K. Hermansen, G. Riccardi, A. A. Rivellese, L. C. Tapsell, C. Nalsen, L. Berglund, A. Louheranta, B. M. Rasmussen, G. D. Calvert, A. Maffettone, E. Pedersen, I. B. Gustafsson, L. H. Storlien: Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU Study. Diabetologia 44 (2001) 312– 319. 61 A. E. Brynes, C. M. Edwards, A. Jadhav, M. A. Ghatei, S. R. Bloom, G. S. Frost: Diet-induced change in fatty acid composition of plasma triacylglycerols is not associated with change in glucagon-like peptide 1 or insulin sensitivity in people with type 2 diabetes. Am. J. Clin. Nutr. 72 (2000) 1111– 1118. 62 F. B. Hu: The Mediterranean diet and mortality - olive oil and beyond. N. Engl. J. Med. 348 (2003) 2595– 2596. 63 C. K. Lardinois, G. H. Starich: Polyunsaturated fats enhance peripheral glucose utilization in rats. J. Am. Coll. Nutr. 10 (1991) 340– 345. 64 L. H. Storlien, J. A. Higgin, T. C. Thomas, M. A. Brown, H. Q. Wang, X. F. Huang, P. L. Else: Diet composition and insulin action in animal models. Br. J. Nutr. 83 (2000) S 85–S 90. 65 M. Borkman, L. H. Storlien, D. A. Pan, A. B. Jenkins, D. J. Chisholm, L. V. Campbell: The relation between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids. N. Engl. J. Med. 328 (1993) 238– 244. 66 E. J. Mayer-Davis, J. H. Monaco, H. M. Hoen, S. Carmichael, M. Z. Vitolins, M. J. Rewers, S. M. Haffner, M. F. Ayad, R. N. Bergman, A. J. Karter: Dietary fat and insulin sensitivity in a triethnic population: the role of obesity. The Insulin Resistance Atherosclerosis Study (IRAS). Am. J. Clin. Nutr. 65(1) (1997) 79– 87. 67 E. J. Feskens, J. G. Loeber, D. Kromhout: Diet and physical activity as determinants of hyperinsulinemia: the Zutphen Elderly Study. Am. J. Epidemiol. 140(4) (1994) 350– 360. 68 E. J. Mayer, B. Newman, C. P. Quesenberry, Jr, J. V. Selby: Usual dietary fat intake and insulin concentrations in healthy women twins. Diabetes Care 16(11) (1993) 1459– 1469. 69 J. Salmeron, F. B. Hu, J. E. Manson, M. J. Stampfer, G. A. Colditz, E. B. Rimm, W. C. Willett: Dietary fat intake and risk of type 2 diabetes in women. Am. J. Clin. Nutr. 73(6) (2001) 1019– 1026. 70 K. A. Meyer, L. H. Kushi, D. R. Jacobs, Jr, A. R. Folsom: Dietary fat and incidence of type 2 diabetes mellitus in older Iowa women. Diabetes Care 24 (2001) 1528– 1535. 71 E. J. Feskens: Can Diabetes Be Prevented by Vegetable Fat? Diabetes Care 24 (2001) 1517– 1518. 72 E. B. Hu, R. M. van Dam, S. Liu: Diet and risk of type II diabetes; the role of types of fat and carbohydrate. Diabetologia 44 (2001) 805– 817. 73 A. A. Rivellese, C. De Natale, S. Lilli: Type of dietary fat and insulin resistance. Ann. NY Acad. Sci. 967 (2002) 329– 935. 74 L. H. Storlien, E. W. Kraegen, D. J. Chisholm, G. L. Ford, D. G. Bruce, W. S. Pascoe: Fish oil prevents insulin resistance induced by high-fat feeding in rats. Science 237(4817) (1987) 885– 888. 75 A. A. Rivellese, A. Maffettone, C. Iovine, L. Di Marino, G. Annuzzi, M. Mancini, G. Riccardi: Long-term effects of fish oil on insulin resistance and plasma lipoproteins in NIDDM patients with hypertriglyceridemia. Diabetes Care 19(11) (1996) 1207– 1213. 76 P. Rubba, A. Iannuzzi: n-3 to n-6 fatty acids for managing hyperlipidemia, diabetes, hypertension and atherosclerosis: is there evidence? Eur. J. Lipid Sci. Technol. 103 (2001) 407– 418. 77 H. T. Westerveld, J. C. de Graaf, H. H. van Breugel, J. W. Akkerman, J. J. Sixma, D. W. Erkelens, J. D. Banga: Effects of low-dose EPA-E on glycemic control, lipid profile, lipoprotein(a), platelet aggregation, viscosity, and platelet and vessel wall interaction in NIDDM. Diabetes Care 16(5) (1993) 683– 688. 78 W. E. Connor, M. J. Prince, D. Ullmann, M. Riddle, L. Hatcher, F. E. Smith, D. Wilson: The hypotriglyceridemic effect of fish oil in adult-onset diabetes without adverse glucose control. Ann. NY Acad. Sci. 683 (1993) 337– 340. 79 I. Puhakainen, I. Ahola, H. Yki-Jarvinen: Dietary supplementation with n-3 fatty acids increases gluconeogenesis from glycerol but not hepatic glucose production in patients with non-insulin-dependent diabetes mellitus. Am. J. Clin. Nutr. 61(1) (1995) 121– 126. 80 A. A. Rivellese: Monounsaturated and marine omega-3 fatty acids in NIDDM patients. Ann. NY Acad. Sci. 827 (1997) 302– 309. 81 C. R. Sirtori, G. Crepaldi, E. Manzato, M. Mancini, A. Rivellese, R. Paoletti, F. Pazzucconi, F. Pamparana, E. Stragliotto: One-year treatment with ethyl esters of n-3 fatty acids in patients with hypertriglyceridemia and glucose intolerance: reduced triglyceridemia, total cholesterol and increased HDL-C without glycemic alterations. Atherosclerosis 137(2) (1998) 419– 427. 82 A. Trichopoulou, T. Costacou, C. Bamia, D. Trichopoulos: Adherence to a Mediterranean diet and survival in a Greek population. N. Engl. J. Med. 348 (2003) 2599– 2608. Citing Literature Volume106, Issue1January 2004Pages 61-67 ReferencesRelatedInformation